Folia Pharmacologica Japonica
Online ISSN : 1347-8397
Print ISSN : 0015-5691
ISSN-L : 0015-5691
Review on New Drug
Clinical benefit of eribulin (Halaven®) in the treatment of advanced soft tissue sarcoma patients and the novel anti-tumor mechanisms
Noriyuki KoyamaShigeru TaniguchiKotaro KodamaOsamu TohyamaHiroki HasegawaTaro Semba
Author information
JOURNAL FREE ACCESS

2016 Volume 148 Issue 6 Pages 329-333

Details
Abstract
[in Japanese]
Content from these authors
© 2016 by The Japanese Pharmacological Society
Previous article
feedback
Top